Clinical trial
Prospective, Randomized Phase III Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
NCT03519386 is registered in ClinicalTrials.gov with Glaukos Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Randomized Phase III Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
- Lead sponsor
- Glaukos Corporation
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 26, 2018
- Completion date
- April 2, 2024
- Enrollment
- 590 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.